Skip to Main Content
Prescriber's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • GO TO CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Renal & Urology
  4. Drug Use in Renal Insufficiency
  5. Endocrinology

Endocrinology

  • Benign Prostatic Hypertrophy (15)
  • Drug-Induced Nephrotoxicity (103)
  • Drug Use in Renal Insufficiency (207)
    • Bone/Joint and Rheumatology (18)
    • Cardiology (83)
    • Endocrinology (42)
    • Gastroenterology (21)
    • Hematology/Oncology (14)
    • Infectious Diseases (47)
    • Men's Health (1)
    • Neurology/Psychiatry (14)
    • Women's Health (3)
  • Hyperkalemia (11)
  • Hypernatremia (2)
  • Hyponatremia (6)
  • Incontinence (4)
  • Kidney Cancer (1)
  • Kidney Disease (27)
  • Kidney Stones (13)
  • Nephrology (52)
  • Overactive Bladder (22)
  • Resources (58)
  • Urinary Retention (6)
  • UTIs (62)
  • Urine Drug Testing (10)
16 - 30 of 42 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Don't Rule Out Sulfonylureas for Type 2 Diabetes January 2018
Commentary: Calculating Renal Function in Adults December 2017
Algorithm: Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes March 2017
Algorithm: Management of New-Onset Type 2 Diabetes October 2016
PL Voices: Renal Effects of Diabetes Medications August 2016
Article: Monitor Kidney Function in Patients Starting an SGLT2 Inhibitor August 2016
Commentary: Clinical Use of Metformin in Special Populations June 2016
Article: Feel Comfortable Using Metformin in More Diabetes Patients With Kidney Disease June 2016
PL Voices: Appropriate Use of Metformin in Patients with Kidney Disease May 2016
Other: Adverse Event Reporting Program July 2015
Other: SGLT2 Inhibitors (Flozins) and Ketoacidosis/Urinary Tract Infections (Dec 2015) July 2015
Article: Stop Flozins in Patients Who Complain About Ketoacidosis Symptoms July 2015
Article: Use eGFR Instead of Cockcroft Gault for "Flozin" Dosing February 2015
PL Voices: Role of SGLT2 Inhibitors for Type 2 Diabetes October 2014
Article: Advise Taking "Flozins" in the Morning October 2014
  • « Prev
  • 1
  • 2
  • 3
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved